CARsgen Therapeutics Revenue
Biotechnology Research • 
Xuhui District, Shanghai, China • 51-100 Employees
CARsgen Therapeutics revenue & valuation
| Annual revenue | $21,700,000 |
| Revenue per employee | $230,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $69,200,000 |
| Total funding | $186,000,000 |
Key Contacts at CARsgen Therapeutics
Mohammad Nour
Associate Director, Manufacturing & Cmc Head
Anthony Yu
Director Of Strategic Planning
Ling Ling
Sr. Director Head Of Clinical Operations
Allen He
Assistant Director Clinical Drug Supply
Allen He
Assistant Procurement Director
Margaret Cai
Senior Director Supply Chain
Linlin Yang
Associate Director, Project Management
珺 肖
Senior Medical Director
Company overview
| Headquarters | 1F, Building 2, No.466, Yindu Rd, Shanghai, Shanghai 200231, CN |
| Phone number | +8620250912 |
| Website | |
| SIC | 283 |
| Keywords | Oncology, Solid Tumors, Hematologic Malignancies, Car T-Cell Therapies |
| Founded | 2014 |
| Employees | 51-100 |
| Socials |
CARsgen Therapeutics Email Formats
CARsgen Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@carsgen.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@carsgen.com | 50% |
{first name} | john@carsgen.com | 33.3% |
{first initial}.{last name} | j.doe@carsgen.com | 16.7% |
About CARsgen Therapeutics
CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. CARsgen has internally developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable. Media contact: pr@carsgen.com
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
CARsgen Therapeutics has 37 employees across 11 departments.
Departments
Number of employees
CARsgen Therapeutics Tech Stack
Discover the technologies and tools that power CARsgen Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Tag managers
Security
Font scripts
JavaScript graphics
JavaScript libraries
UI frameworks
Analytics
Cameroon
United Arab Emirates
Norway
Frequently asked questions
4.8
40,000 users
